Lophius Biosciences GmbH

MULTITRACK

Computer software for use with apparatus and instruments for analysis of tests based on microtiter plates; test kits, composed of reaction vessels, tubes, microtiter plates, filter plates for laboratory purposes and test components, in particular suspensions with carrier particles and biomolecules and similar substances; detection apparatus; microtiter plates; filter plates for laboratory purposes;Chemical, biochemical and biological products and preparations for medical purposes, namely, diagnostic and analysis preparations, eukaryotic cells, cultures of microorganisms, nucleic acids, polypeptides, proteins, in particular antibodies and T-cell proteins and enzymes, in particular for infectious and autoimmune diseases;MULTI TRACK;Chemical, biochemical and biological products and preparations for industrial and scientific purposes, namely, diagnostic and analysis preparations, eukaryotic cells, cultures of microorganisms, nucleic acids, polypeptides, proteins, in particular antibodies and T-cell proteins and enzymes;Medical and veterinary medical services; services of medical doctors and hospitals, in particular disease treatment and prophylaxis; consultancy in the field of human medicine, veterinary medicine and pharmacy;Molecular biological or biotechnological laboratory services, in particular research and development in the field of human medicine and veterinary medical diagnostics and therapy; identification of epitopes and identification of target structures for the development of medicines and vaccines; development of medicines, vaccines, diagnostic preparations, analysis and diagnostic apparatus and systems for third parties; development of technologies for third parties for scientific and industrial research and production, in particular T-cell-based products for diagnosis, therapy and prevention of autoimmune and infectious disorders; development of test procedures and test kits for third parties; scientific and technological services, in particular development of eukaryotic cells, microorganisms, nucleic acids, polypeptides, proteins, in particular antibodies and T-cell proteins, enzymes; development of computer programs and databases; scientific and technical analysis of cells, nucleic acids and polypeptides by means of computer programs and databases; medical research laboratory services and veterinary laboratory services;

T-ACTIVATED

Medicines for use in treating infectious diseases and autoimmune disorders; pharmaceutical and veterinary preparations for use in treating infectious diseases and autoimmune disorders; vaccines; diagnostic and analysis preparations for medical purposes, medicines and medical diagnostic preparations, namely eukaryotic cells, microorganisms, nucleic acids, polypeptides, proteins, in particular antibodies, and enzymes, all for diagnosing and treating infectious diseases and autoimmune disorders;Chemicals for use in industry and science, biochemical and biological products for in vitro and in vivo scientific use; diagnostic and analysis preparations other than for medical or veterinary purposes, eukaryotic cells for scientific, laboratory or medical research, cultures of microorganisms other than for medical and veterinary use, nucleic acids for laboratory use, biochemicals, namely, polypeptides for laboratory use, proteins, in particular antibodies for scientific, laboratory or medical research, enzymes for industrial purposes, all for use in industry and science;Scientific research; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceuticals; molecular biological or biotechnological laboratory services, in particular research and development in the field of medical and veterinary medical diagnostics and therapy; scientific research and analysis services relating to identification of epitopes and identification of target structures for the development of medicines and vaccines; development of medicines, vaccines, diagnostic preparations, analysis and diagnostic apparatus and systems; development of technologies for scientific and industrial research and production, for diagnosis, therapy and prevention of autoimmune and infectious disorders, development of test procedures and test kits for diagnosis and therapy for autoimmune and infectious disorders; development of pharmaceutical, scientific and laboratory new products, namely eukaryotic cells, microorganisms, nucleic acids, polypeptides, proteins, in particular antibodies and T-cell proteins, enzymes; development of computer programs and databases; scientific research, namely, analysis of cells, nucleic acids and polypeptides by means of computer programs and databases;